Transcatheter Treatment of Tricuspid Valve

Tricuspid valve replacement is not a common operation and, in most series, is associated with high postoperative mortality. Although bioprosthetic valves appear to have improved the performance early after surgery, these valves will inevitably experience wear and degeneration, requiring a second implant. Redo valve surgery for bioprosthetic valve failure is challenging. In this context, there has been an understandable interest in percutaneous valve therapy to extend the life span of failing tricuspid valve prostheses.